Profit: Gene therapy for intervertebral disc degeneration (Q3301670): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item: Edited by the beneficiary bot - attach the beneficiary based on the string) |
(Removed claims) |
||||||
| Property / EU contribution | |||||||
| |||||||
| Property / EU contribution: 9,991.27 Euro / rank | |||||||
| Property / co-financing rate | |||||||
| |||||||
| Property / co-financing rate: 0.8 percent / rank | |||||||
Revision as of 12:14, 27 October 2021
Project Q3301670 in Germany
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Profit: Gene therapy for intervertebral disc degeneration |
Project Q3301670 in Germany |
Statements
1,248,908.31 Euro
0 references
1 December 2019
0 references
30 June 2022
0 references
Genequine Biotherapeutics GmbH
0 references
52°5'24.72"N, 13°10'27.08"E
0 references
Luckenwalde, Stadt
0 references
Identifiers
DE_TEMPORARY_4472
0 references